Ranibizumab for the treatment of retinopathy of prematurity: systematic review and meta-analysis

Anti-VEGF drugs like ranibizumab can be used to treat retinopathy of prematurity (ROP) by halting the formation of abnormal blood vessels, or lasers can be used to burn the edges of the retina where these vessels are present. The objective is to compare the efficacy for ROP between ranibizumab and l...

Descripción completa

Detalles Bibliográficos
Autores principales: Alva, Niza, Martínez, Alex R., Ortiz-Saavedra, Brando, Montes-Madariaga, Elizbet S., Cotrina, Alonso, Caballero-Alvarado, José A., Sah, Ranjit, Barboza, Joshuan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436596/
https://www.ncbi.nlm.nih.gov/pubmed/37601137
http://dx.doi.org/10.3389/fped.2023.1202927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436596/
https://www.ncbi.nlm.nih.gov/pubmed/37601137
http://dx.doi.org/10.3389/fped.2023.1202927

Ejemplares similares